Welcome to BioReagent Hub Hotline:19920083827
Article Detail

Key Points for Methodological Performance Verification of Linezolid and Voriconazole Assay Kits

AI Generated
2026-09-24 14:20 Author:ABIOP Source:AI 生成 Views 167
Back to List
Key Points for Methodological Performance Verification of Linezolid and Voriconazole Assay Kits

Necessity and Standards of Methodological Validation

Before the linezolid and voriconazole assay kits (liquid chromatography-tandem mass spectrometry) are introduced into the clinical laboratory, comprehensive methodological performance validation must be conducted to ensure reliable test results. The validation process typically refers to CLSI C62-A or relevant industry guidelines, covering parameters such as precision, accuracy, linearity, lower limit of quantification, matrix effects, selectivity, carryover, and stability. Laboratories should develop validation protocols based on the kit instructions and their own conditions, and must not directly apply the manufacturer's data. The following discussion focuses on several core indicators.

Evaluation of Precision and Accuracy

Precision is generally evaluated by repeated measurement of low, medium, and high concentration quality control samples, including intra-run and inter-run precision. The common requirement is a coefficient of variation (CV) within 15% (which may be relaxed to 20% near the lower limit of quantification). Accuracy can be assessed through recovery experiments or comparison with reference methods, with recovery typically between 85% and 115%. For linezolid and voriconazole, because their physicochemical properties differ, the precision and accuracy of each analyte must be validated separately to ensure that performance requirements are met within their respective therapeutic concentration ranges. Laboratories should run at least 3 consecutive batches and collect no fewer than 20 replicate data points.

Linear Range and Lower Limit of Quantification

The linear range should cover the clinically expected concentration interval, generally requiring a correlation coefficient r >= 0.99. The lower limit of quantification is defined as the lowest concentration that can be accurately quantified, with a signal-to-noise ratio usually no less than 10:1, and with precision and accuracy meeting acceptance criteria. For voriconazole, because its therapeutic window is relatively narrow, accurate quantification in the low concentration range is particularly important. During validation, laboratories need to prepare at least 6-8 non-zero calibrators and examine the deviation of the linear fit. If a nonlinear response is observed, weighted regression or quadratic fitting may be considered, but this should be explained in the method validation report.

Matrix Effects and Selectivity

Matrix effects are a common source of interference in liquid chromatography-tandem mass spectrometry, mainly caused by ion suppression or enhancement from co-eluting endogenous substances. The evaluation method usually uses post-extraction addition experiments: comparing the response ratio of matrix-matched standard solutions to pure solvent standard solutions. If the ratio is between 0.85 and 1.15, the matrix effect is considered acceptable. In addition, interference from abnormal samples such as hemolyzed, lipemic, and icteric samples should also be examined. Selectivity validation should ensure that no endogenous substances in the blank matrix produce significant signals at the retention time of the target analytes (below 20% of the lower limit of quantification).

Stability Assessment and Quality Control

Stability includes the stability of samples under conditions such as room temperature, refrigeration, freeze-thaw cycles, and placement in the autosampler tray after processing. Generally, at least two concentration levels, low and high, should be examined under each condition, with deviation within +/-15%. In terms of quality control, internal quality control rules (such as Westgard rules) should be established, each batch should include at least two quality control samples at low and high concentrations, and laboratories should regularly participate in external quality assessment programs. The calibrators and quality control materials of the kit should be brought to room temperature before use, avoiding repeated freeze-thaw cycles. Through systematic methodological validation and continuous quality monitoring, laboratories can ensure the long-term reliability of linezolid and voriconazole assay results.

Comments0

Sign in to comment on this article

✉Email 💬Message 👤Member
↑Top